Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Bofanglutide

Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Receiving Positive Airway Pressure (PAP) Therapy

Gan & Lee Pharmaceuticals · Phase 3 · Not yet recruiting · Enrollment 140

NCT07501832

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
GZR18 injectionn/rn/rn/rn/r
Placebon/rn/rn/rn/r

Not shown

  • GZR18 injection: endpoint not reported
  • Placebo: endpoint not reported